PaxMedica announced that the Company has launched a newly updated corporate website. Howard Weisman, Chief Executive Officer of PaxMedica, commented, "Our new website underscores our ongoing commitment to develop therapeutic advancements to treat core symptoms of autism and other potentially related disorders with intractable neurologic symptoms. The refreshed site represents the first step in providing a more robust platform for sharing information with our stakeholders, including families and investors, who are interested in our research."
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on PXMD:
- PaxMedica, Inc. Launches Updated Corporate Website at PaxMedica.com
- PaxMedica Soars on Equity Deal with Lincoln Park Capital
- PaxMedica, Inc. Enters Into Committed Equity Investment Agreement for up to $20 Million With Lincoln Park Capital
- PaxMedica, Inc. Provides Business Update and Reports Third Quarter 2022 Financial Results